CLSI M45-A2

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition, M45A2E

Clinical and Laboratory Standards Institute, 08/01/2010

Publisher: CLSI

File Format: PDF

$114.00$228.69

Description

Published:01/08/2010

Pages:100

This document provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI documents M02 or M07. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.

More CLSI standard pdf

CLSI MM05A

Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline, MM05-A

$103.00 $206.29

CLSI LIS09-A

Standard Guide for Coordination of Clinical Laboratory Services Within the Electronic Health Record Environment and Networked Architectures, LIS9AE

$138.00 $277.36

CLSI LIS06-A

Standard Practice for Reporting Reliability of Clinical Laboratory Information Systems, LIS6AE

$139.00 $278.67

CLSI M24A

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A

$135.00 $271.99